Venus Remedies gains DCGI approval for trials on molecule

05/6/2009 | RTT News

Venus Remedies has received clearance from the Drugs Controller General of India to undertake Phase I clinical trials for VRP 1620, a molecule administered through injection that can be used to diagnose solid tumors in humans. If used with PET/CT, the drug might help pinpoint cancer stage and aid oncologists in determining the right course of therapy and monitoring treatment progress.

View Full Article in:

RTT News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC